| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c1ecb5e1996c0c75e561d359fd2cb115
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a4f5a0e665125b470ba6822e1dac5534 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J43-003
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-58 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-071
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate |
2009-10-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9b06db7bb3cb1b503c23803585c25193
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e43336904fa41ccd7945860b4fb360a9 |
| publicationDate |
2010-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2010048524-A1 |
| titleOfInvention |
Novel C-17-Heteroaryl Steroidal CYP17 Inhibitors/Antiandrogens;Synthesis In Vitro Biological Activities, Pharmacokinetics and Antitumor Activity |
| abstract |
Described are steroidal C-17 benzoazoles, pyrimidinoazoles (azabenzoazoles) and diazines. Methods for their synthesis are also described, which include methods having a step of nucleophilic vinylic “addition-elimination” substitution reaction of 3β-acetoxy-17-chloro-16-formylandrosta-5,16-diene or analogs thereof and benzoazole or pyrimidinoazole nucleophiles and methods having a palladium catalyzed cross-coupling reaction of 17-iodoandrosta-5,16-dien-3β-ol or analogs thereof with tributylstannyl diazines. The compounds are potent inhibitors of human CYP17 enzyme as well as potent antagonists of both wild type and mutant androgen receptors (AR). The compounds are useful for the treatment of human prostate cancer. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9884067-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9808472-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011034428-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9387216-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9439912-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9359395-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9295679-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011118219-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011160170-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9156878-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9018198-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011105445-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8785423-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10098896-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8791094-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8791095-B2 |
| priorityDate |
2008-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |